Diederik De Cock Selected Research

Diederik De Cock Research Topics

Disease

21	Rheumatoid Arthritis 10/2022 - 01/2015
5	Pain (Aches) 10/2022 - 01/2021
4	Juvenile Arthritis (Juvenile Idiopathic Arthritis) 01/2021 - 01/2019
3	Fatigue 10/2022 - 01/2021
2	Necrosis 10/2022 - 01/2020
2	Rheumatic Diseases (Rheumatism) 01/2020 - 01/2019
2	Infections 01/2019 - 01/2018
1	Arthritis (Polyarthritis) 10/2021
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2021
1	Asthenopia (Eyestrain) 01/2021
1	Connective Tissue Diseases (Connective Tissue Disease) 01/2021
1	Uveitis 01/2020
1	Drug-Related Side Effects and Adverse Reactions 03/2019
1	Phobic Disorders (Phobia) 03/2019
1	Exanthema (Rash) 03/2019
1	Drug Hypersensitivity (Drug Allergy) 03/2019
1	Leukopenia 03/2019
1	Macrophage Activation Syndrome 01/2019
1	Neoplasms (Cancer) 12/2018
1	Joint Diseases (Joint Disease) 03/2017

Drug/Important Bio-Agent (IBA)

11	GlucocorticoidsIBA 06/2021 - 01/2015
9	Methotrexate (Mexate)FDA LinkGeneric 06/2021 - 04/2015
6	Biological ProductsIBA 01/2020 - 10/2018
5	Antirheumatic Agents (DMARD)IBA 10/2022 - 01/2015
4	Rituximab (Mabthera)FDA Link 01/2020 - 01/2017
3	Leflunomide (Arava)FDA LinkGeneric 09/2020 - 01/2020
2	Abatacept (Orencia)FDA Link 10/2022 - 01/2020
2	Janus Kinase InhibitorsIBA 10/2022 - 01/2020
2	Tumor Necrosis Factor InhibitorsIBA 10/2022 - 01/2019
2	ametantrone (HAQ)IBA 10/2021 - 01/2021
2	Pharmaceutical PreparationsIBA 01/2021 - 01/2020
2	C-Reactive ProteinIBA 01/2021 - 03/2017
2	Tramadol (K315)FDA LinkGeneric 01/2021 - 01/2021
2	Opioid Analgesics (Opioids)IBA 01/2021 - 01/2021
2	Adalimumab (Humira)FDA Link 01/2020 - 01/2020
2	Etanercept (Enbrel)FDA Link 01/2020 - 01/2020
2	Sulfasalazine (Azulfidine)FDA LinkGeneric 01/2020 - 01/2020
2	Infliximab (Remicade)FDA Link 01/2020 - 01/2020
2	tocilizumab (atlizumab)FDA Link 01/2020 - 01/2019
1	Interleukin-6 InhibitorsIBA 10/2022
1	Prostaglandins AIBA 10/2022
1	Indicators and Reagents (Reagents)IBA 04/2022
1	Biomarkers (Surrogate Marker)IBA 01/2021
1	Acetaminophen (Paracetamol)FDA LinkGeneric 01/2021
1	Antidepressive Agents (Antidepressants)IBA 01/2021
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2021
1	Analgesics (Analgesic Drugs)IBA 01/2021
1	GLPG0634IBA 01/2020
1	baricitinibIBA 01/2020
1	upadacitinibIBA 01/2020
1	tofacitinibIBA 01/2020
1	golimumab FDA Link 01/2020
1	sarilumabIBA 01/2020
1	Certolizumab Pegol FDA Link 01/2020
1	Janus KinasesIBA 01/2020
1	Biosimilar PharmaceuticalsIBA 01/2020
1	EnzymesIBA 03/2019
1	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 01/2019

Therapy/Procedure

5	Therapeutics 10/2022 - 01/2015
3	Remission Induction 01/2020 - 01/2015
1	Ambulatory Care (Outpatient Care) 08/2021
1	Aftercare (After-Treatment) 01/2020